Zotefoams appoints Dr Lynn Drummond as Chair Designate

Zotefoams plc (LON:ZTF), a world leader in cellular materials technology, has announced details of changes to its Board of Directors.

In line with the provisions of the UK Corporate Governance Code, the term of office of the existing Chair of the Company, Steve Good, is due to end in 2023. Following an assessment of the Board’s existing skillsets against those required to deliver the Company’s strategy, a search process led by the Senior Independent Director and supported by Korn Ferry was initiated in mid-2022 to identify and appoint a new Chair.

The search has been successfully concluded and we are pleased to announce the appointment of Dr Lynn Drummond as an Independent Non-Executive Director and Chair Designate.

Lynn is currently Chair and Pro-Chancellor of the University of Hertfordshire and a Board mentor for Criticaleye. Previously, she was a Non-Executive Director with Venture Life Group plc, RPC Group plc, Infirst Healthcare, Shield Holdings AG, Allocate Software plc, Consort Medical plc and Alimentary Health Ireland. Lynn spent 16 years as a Managing Director within Investment Banking for Rothschild. Prior to Rothschild, Lynn worked in the Cabinet Office in London as Private Secretary to the Chief Scientific Advisor. She has also been Chairman of Trustees for Breast Cancer Haven and was on the University of Cambridge, Centre for Science and Policy Development Group. Lynn holds a Bachelor of Science Degree in Chemistry from the University of Glasgow and a PhD in Biochemistry from the University of London. She is a Fellow of the Royal Society of Chemistry and a Fellow of the Royal Society of Edinburgh.

Lynn will take over as Chair following Zotefoams’ Annual General Meeting on 24 May 2023, at which point Steve will retire from the Board.

Douglas Robertson, Senior Independent Director, said: “On behalf of the Board, I would like to thank Steve for his significant contribution to the Zotefoams Group and, in particular, his leadership as Chair. We wish him the best in his future endeavours.”

David Stirling, Group CEO, said: “I am delighted to welcome Lynn to Zotefoams. Lynn brings considerable knowledge across a number of functions and sectors, including a long and distinguished career in life sciences. She brings extensive and relevant quoted-company experience and expertise to the Group. I look forward to working with her as we focus on delivering the next phase of our growth strategy.”

Lynn Drummond said: “Zotefoams is a pioneer in cellular materials with the purpose of creating optimal material solutions for the benefit of society. I look forward to working with the Board as we focus on delivering long-term, sustainable growth in the interests of all our stakeholders.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Share on facebook
    Facebook
    Share on twitter
    Twitter
    Share on linkedin
    LinkedIn
    ZoteFoams

    More articles like this

    ZoteFoams

    Zotefoams to announce preliminary results on 21 March 2023

    Zotefoams plc (LON:ZTF), a world leader in cellular materials technology, will announce preliminary results for the year ended 31 December 2022 on Tuesday 21 March 2023. An analyst meeting will take place at 9.30am on the day. Analysts

    ZoteFoams

    Zotefoams looking to scale up pilot trials following acquisition (LON:ZTF)

    Zotefoams’ David Stirling discusses the acquisition of Refour, how it fits in the business, being able to offer a wide choice of recycling packaging, what Torben Anderson brings to the business and what investors can expect in the next 6-12 months in this exclusive interview with DirectorsTalk.

    ZoteFoams

    Zotefoams completes acquisition of Refour ApS

    Zotefoams plc (LON:ZTF), the UK-headquartered specialist in advanced cellular materials, completes the acquisition of the assets and intellectual property of Refour ApS (Skandeborg, Denmark) for a modest cash consideration. In addition, Torben Andersen, Refour CEO, will join the

    ZoteFoams

    Zotefoams achieves record third quarter sales performance

    Zotefoams plc (LON:ZTF), a world leader in cellular materials technology, has provided a trading update for the nine months ended 30 September 2022 and in respect of its financial year ending 31 December 2022. Zotefoams is pleased to report

    ZoteFoams

    Zotefoams announce impressive results following independent assessment

    Zotefoams plc (LON:ZTF), a world leader in cellular materials technology, has announced impressive results following a recent independent Life Cycle Assessment conducted on Zotefoams’ recyclable mono-material barrier beverage carton packaging ReZorce. The study was conducted by Intertek, a global

    ZoteFoams

    Zotefoams results and presentation date

    Zotefoams plc (LON:ZTF), a world leader in cellular materials technology, have announced that they will deliver its interim results for the six months to 30th June 2022 on the 9th August 2022. An analyst meeting will take place at

    No more posts to show